UNSPSC 51143405: Belladonna/ergotamine/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN105. This VA Drug Class (CN105) classifies this compound as belonging to the group ANTIMIGRAINE AGENTS.

UNSPSC 51143405 Belladonna/ergotamine/phenobarbital is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems rather than the pharmaceutical compounds named in the code. This mismatch suggests the code does not accurately capture the county's actual procurement need or that the county misclassified the opportunity in the UNSPSC taxonomy.

Seminole County Community Health posted the IFB seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to its Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The procurement requires vendors to handle all shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation and commercial general liability insurance. The contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period permitting termination at will. No explicit set-aside designations for disadvantaged enterprises appear in the solicitation, though FEMA funding may introduce additional federal compliance requirements. The code shows insufficient recent activity to characterize issuing-body mix or geographic spread beyond this single Florida county opportunity.